Glioblastoma

Glioblastoma is a highly aggressive form of malignant brain tumor. It originates from glial cells, which are the supporting and protective cells in the brain. Glioblastoma is often classified as a glioma, meaning it originates from glial cells.

Glioblastoma usually involves groups of abnormal cells that form large tumors with a cystic structure and new blood vessels inside. These new blood vessels provide oxygen and nutrients to the tumor, which helps it grow.

Symptoms of glioblastoma may include headaches, seizures, personality changes, vision and motor coordination problems, and neurological deficits depending on the location of the tumor in the brain.

Treatment for glioblastoma usually involves a combination of surgical removal of the tumor (if possible), radiation therapy, and chemotherapy.

[ 1 ], [ 2 ], [ 3 ], [ 4 ]

Epidemiology

Glioblastoma is a malignant brain tumor that develops from glial cells, the cells that support and nourish nerve cells. The epidemiology of glioblastoma may include the following aspects:

1. Incidence: Glioblastoma accounts for approximately 15-20% of all primary brain tumors.
2. Age: This tumor is most often diagnosed in adults and older adults, although it can occur at any age. The average age of diagnosis is about 64 years.
3. Gender: Glioblastoma is more commonly diagnosed in men than in women.
4. Prevalence: Epidemiologic data may vary across countries and regions. In the United States, the annual incidence of glioblastoma is estimated to be approximately 3 to 4 cases per 100,000 people per year.
5. Risk factors: Understanding the exact causes of glioblastoma remains limited. Some possible risk factors include exposure to the brain and genetic predisposition. Some studies have also linked glioblastoma to high doses of ionizing radiation, but this factor is not the primary cause.
6. Prognosis: Glioblastoma usually has a poor prognosis. Surgical removal of the tumor, radiation therapy, and chemotherapy may help prolong survival, but a complete cure is usually not possible. The average life expectancy after diagnosis of glioblastoma is usually estimated at several years.

The level of epidemiological information about glioblastoma varies by country and region. Monitoring and research in this area helps to better understand the prevalence, risk factors, and treatment options for this tumor and to develop more effective diagnostic and treatment methods.

Causes glioblastomas

The causes of glioblastoma, like many other brain tumors, are not yet fully understood, and research in this area is ongoing. However, there are some factors and conditions that may increase the risk of developing this tumor:

1. Genetic predisposition: Heredity may play a role in the development of glioblastoma. Some people may have genetic changes or a family history of brain cancer that increases their risk.
2. Radiation: High-dose ionizing radiation, such as radiotherapy to treat other brain or head tumors, may be a risk factor for developing glioblastoma.
3. Age: The risk of developing glioblastoma increases with age, and this type of tumor is more often diagnosed in adults.
4. Previous brain tumors: People who have had previous brain tumors may have an increased risk of developing glioblastoma, especially if their previous tumors were not removed effectively.
5. Environmental factors: Some studies have linked long-term exposure to chemicals such as mercury, resorcinol, and some pesticides to an increased risk of developing brain tumors, including glioblastoma. However, the relationship between these factors and the development of brain tumors requires further study.

[ 5 ]

Pathogenesis

The pathogenesis of glioblastoma involves a number of changes and events that lead to the development of the tumor. The main aspects of the pathogenesis of glioblastoma are presented below:

1. Genetic mutations: Glioblastoma is often associated with genetic mutations. One of the most well-known mutations associated with glioblastoma is the EGFR (epidermal growth factor) gene mutation. This mutation can lead to overactivation of signaling pathways that promote tumor cell growth and division.
2. TP53 Gene Mutations: The TP53 gene is a tumor suppressor gene that plays a role in regulating the cell cycle and preventing uncontrolled cell growth. Mutations in TP53 can lead to loss of its normal function and accelerated tumor growth.
3. **IDH (isocitrate dehydrogenase) gene mutations: Some glioblastomas contain mutations in the IDH gene, which can affect the metabolism of tumor cells and promote their growth.
4. Genetic instability: Glioblastomas are often characterized by genetic instability, which can lead to the accumulation of additional genetic changes and alteration of the tumor biology.
5. Angiogenesis (formation of new vessels): Glioblastoma can stimulate the formation of new vessels (angiogenesis), which provides tumors with oxygen and nutrients, supporting their growth and survival.
6. Inflammation and immune response: Inflammation and immune responses may also play a role in the pathogenesis of glioblastoma. Immune cells can target the tumor, but the tumor may also develop mechanisms to evade immune control.

The pathogenesis of glioblastoma is a complex and multifaceted process. Research in this area is ongoing, and a deeper understanding of the molecular and genetic mechanisms of this tumor may contribute to the development of more effective diagnostic and therapeutic methods.

Symptoms glioblastomas

Symptoms of glioblastoma can vary depending on the location of the tumor in the brain and its size. The tumor can put pressure on surrounding tissue, including nerve cells, which can cause a variety of neurological symptoms. Some common symptoms of glioblastoma include:

1. Headache: This is one of the most common symptoms. Headaches are often severe, worse in the morning or with physical activity.
2. Nausea and vomiting: These symptoms may occur due to pressure on the brain structures that control the gag reflex.
3. Vision changes: Glioblastoma located in certain areas of the brain can cause changes in vision, including double vision, blurred vision, or partial blindness.
4. Seizures: Some patients with glioblastoma may have seizures or epileptic fits.
5. Changes in behavior and memory: Glioblastoma, by affecting different parts of the brain, can cause changes in memory, thinking, mood, and behavior.
6. Motor deficits: A tumor located in the motor areas of the brain may cause weakness, numbness, or loss of control of the limbs.
7. Displacement of the eyeball (exophthalmia): In rare cases, a glioblastoma that is in close proximity to the eyeball may cause it to become displaced.
8. Problems with speech and coordination: Glioblastoma can affect the areas of the brain responsible for speech and coordination of movements.
9. Decreased consciousness: If the tumor causes a disruption in the drainage of cerebrospinal fluid, this can lead to increased intracranial pressure and decreased consciousness.

Symptoms may appear gradually or suddenly, and they may be intermittent or persistent.

Stages

Glioblastoma, like many other tumors, is classified into stages to assess the spread of the tumor and determine treatment. For glioblastoma, a classification system known as the TNM (Tumor, Nodes, Metastasis) system is often used, which takes into account the size of the tumor (T), the presence of lymph node metastases (N), and the presence of distant metastases (M). However, for some tumors, including glioblastoma, a specific classification is also used that takes into account the characteristics of that particular tumor.

In the case of glioblastoma, the following classification is often used based on the morphological and histological characteristics of the tumor:

1. Grade 4 Glioblastoma (Stage IV): This is the highest level of malignancy. Glioblastoma is fast growing and aggressive. This stage is divided into several subtypes based on the morphology of the cells and other characteristics of the tumor. Grade 4 glioblastoma often requires intensive treatment, including surgical removal, radiation therapy, and chemotherapy.
2. Low-grade glioma (stage I-III): Low-grade gliomas are characterized by slow growth and a less aggressive nature compared to grade IV glioblastoma. They can also be classified into several subtypes based on their morphology and genetic characteristics. Low-grade gliomas are often more treatable and have a longer prognosis, but they can also become more malignant over time.

Glioblastoma stages can vary depending on many factors, including tumor morphology, size, invasiveness, and other factors. Classification and staging are determined by a pathologist after examining biopsy material.

Forms

Glioblastoma is a high-grade and aggressive brain tumor, and there is mainly one type of glioblastoma, which is classified as grade IV glioblastoma on the tumor malignancy scale. It is the most malignant form of glial brain tumors. However, there may be differences in histological structure within glioblastoma, and it can be classified as follows:

1. Classic glioblastoma (GBM): This is the most common type of glioblastoma. The tumor has characteristic features of high cellular density, necrosis, and the ability to grow rapidly and spread invasively into surrounding brain tissue.
2. Glioblastoma mesenchymal (GBM-M): This subtype of glioblastoma has mesenchymal characteristics, and its cells may have the ability to invade and metastasize. It is a more aggressive subtype.
3. Glioblastoma sandstone (GBM-P): The tumor may contain sandstone-like structures, which may be reflected in the morphological pattern.
4. Glioblastoma with giant multinucleated cells (GBM-G): In this case, the tumor contains cells with giant nuclei, which makes them easily recognizable.

It is important to note that glioblastoma is classified based on histology and structural assessment of the tumor by microscopic examination of tissue after biopsy or surgical removal of the tumor. These different forms of glioblastoma may have different characteristics and more or less aggressive behavior, but all require serious treatment and monitoring.

A distinction is also made between:

1. Brainstem Glioblastoma: Glioblastoma that develops in the brainstem is one of the most aggressive and complex types of tumors. It usually has a poor prognosis due to its close proximity to important brain structures and the difficulty of surgical removal.
2. Glioblastoma multiforme: Glioblastoma multiforme is a subtype of glioblastoma that can have a variety of morphologic and cellular characteristics, making its diagnosis and classification more challenging.
3. Polymorphic cell glioblastoma: Polymorphic cell glioblastoma is a subtype of glioblastoma characterized by the presence of different types of cells within the tumor. This may include cells with different morphological features.
4. Isomorphic cell glioblastoma: Isomorphic cell glioblastoma is a subtype in which the tumor cells have a more uniform or similar structure and morphology.

Complications and consequences

Glioblastoma, as a malignant brain tumor, can cause a variety of complications and problems, both as a result of the tumor itself and during treatment. Some of the possible complications of glioblastoma are listed below:

1. Epilepsy: Glioblastoma can irritate nearby areas of the brain and cause seizures, which can lead to epilepsy.
2. Neurological symptoms: The tumor can put pressure on surrounding areas of the brain, causing a variety of neurological symptoms, including problems with vision, hearing, coordination, and movement.
3. Hypertension and hydrocephalus: Fluid accumulation in the cerebral ventricles caused by the tumor can lead to increased intracranial pressure and hydrocephalus.
4. Paralysis and muscle weakness: A tumor located in certain areas of the brain can cause paralysis and muscle weakness, which greatly affects the patient's quality of life.
5. Infections: Because glioblastoma is often treated with surgery and radiation therapy, patients may be at risk for infections, including brain infections.
6. Changes in psychoemotional state: The diagnosis of glioblastoma and its treatment can cause emotional and psychological difficulties in patients, including depression and anxiety.
7. Tumor recurrence: Glioblastoma tends to recur, even after surgical removal and radiation therapy. This complication may require additional treatment and monitoring.
8. Treatment side effects: Treatment for glioblastoma can cause a variety of side effects, including nausea, vomiting, fatigue, hair loss, immune problems, and others.

Complications and sequelae of glioblastoma can be very serious, and treatment often requires a multidisciplinary approach involving oncologists, neurosurgeons, radiologists and other specialists. Early diagnosis and modern treatments can help manage complications and improve patients’ quality of life.

Recurrence of glioblastoma

This is the return of tumor growth after completion of treatment or a period when the disease was under control. Glioblastoma is often characterized by a high tendency to relapse, and this is one of the difficulties in its treatment.

Key aspects of glioblastoma recurrence:

1. Time to recurrence: The time to recurrence can vary from patient to patient. In some people, the tumor may return soon after treatment, while in others, it may take several years.
2. Recurrence site: Recurrence can occur in the same location where the tumor was originally or in another part of the brain. In some cases, the tumor may even spread outside the brain.
3. Treatment for recurrence: Treatment for recurrent glioblastoma may include surgical removal of the tumor (if technically feasible), radiation therapy, and chemotherapy. However, treatment for recurrence may be more challenging due to previous treatments and drug resistance of the tumor.
4. Prognosis: The prognosis for recurrent glioblastoma is often worse than at initial diagnosis. It depends on many factors, including the location and size of the recurrence, the patient's overall health, and the effectiveness of previous treatments.
5. Follow-up: After completion of treatment and during the monitoring period, it is important to undergo regular examinations and brain MRI to detect relapse at an early stage, when treatment measures can still be taken.

Treating recurrent glioblastoma is challenging, and patients often require a multidisciplinary approach involving neurosurgeons, oncologists, and radiologists. The optimal strategy depends on the individual patient and recurrence characteristics. It is important to discuss all available treatment options with your healthcare team to make the best decision for your individual case.

Diagnostics glioblastomas

Diagnosis of glioblastoma usually involves a series of medical and laboratory procedures to establish an accurate diagnosis and determine the characteristics of the tumor. Here are the main steps and methods used in diagnosis:

1. Physical examination and history: The doctor performs a general physical examination and collects information about the patient's symptoms and medical history, including the presence of genetic risk factors or previous medical conditions.
2. Magnetic resonance imaging (MRI): MRI of the brain is the main imaging test for detecting and evaluating a tumor. It provides a detailed image of the brain structure and can determine the size, location, and characteristics of the tumor.
3. Computed tomography (CT): CT may be used along with MRI to provide a more complete picture of the tumor.
4. Biopsy: To determine the exact type of tumor and its grade, a biopsy is usually required, in which a tissue sample is taken from the tumor. This sample is sent for histological examination.
5. Histologic examination: Microscopic examination of the biopsy specimen allows the pathologist to determine the exact type of tumor and its grade.
6. Genetic testing: In some cases, genetic testing is done to look for mutations or changes in genes associated with the development of brain tumors.
7. Positron emission tomography (PET): PET can be used to assess the activity of a tumor and determine how far it has spread.
8. CSF biopsy: Sometimes the cerebrospinal fluid (CSF) that surrounds the brain and spinal cord may contain cancer cells. A CSF biopsy may be done to analyze the contents of the CSF.

After conducting all the necessary tests and receiving an accurate diagnosis, doctors can determine the best treatment plan for the patient.

[ 6 ], [ 7 ], [ 8 ], [ 9 ], [ 10 ]

Treatment glioblastomas

Treatment for glioblastoma, a malignant brain tumor, depends on many factors, including the tumor stage, location, patient age, and overall health. Typically, treatment for glioblastoma involves a combination of the following:

Surgical removal of the tumor

Surgery may be an attempt to remove as much of the tumor as possible. However, glioblastoma is often difficult to treat due to its location and invasiveness. The goal of surgery is to shrink the tumor to improve symptoms and prepare it for subsequent radiation and chemotherapy.

Surgical removal of glioblastoma (GBM) may be part of a comprehensive treatment for this tumor. The surgery is aimed at removing the tumor or part of it to reduce the tumor volume and relieve symptoms, as well as obtaining tissue for biopsy for an accurate diagnosis.

Important points related to surgical removal of glioblastoma:

1. Determining surgical feasibility: It is not always possible to surgically remove the entire GBM tumor, especially if it is located in critical areas of the brain. The surgeon evaluates the tumor's location, size, and proximity to important brain structures before deciding whether to perform surgery.
2. Biopsy: During surgery, a tissue sample is usually taken for a biopsy to determine the type of tumor and its grade.
3. Radical resection: In some cases, if it is safe in terms of surgical technique and tumor location, radical resection of the entire tumor may be attempted to reduce the risk of recurrence. However, even with complete tumor removal, the risk of GBM recurrence remains high.
4. Debulking (partial removal): In most cases, surgeons perform debulking, which means removing part of the tumor to relieve pressure on brain structures and relieve symptoms. This can also improve the effectiveness of subsequent treatments, such as radiation and chemotherapy.
5. Functional studies: Functional brain studies, such as magnetic resonance spectroscopy and functional MRI, may be done before surgery to identify areas of the brain responsible for important functions, such as speech and motor skills, and to minimize the risk of damage to these areas during surgery.
6. Rehabilitation: After surgery, patients often require rehabilitation to restore physical and neurological function, especially if the surgery involved important areas of the brain.
7. Additional treatment: Surgical removal of glioblastoma is usually followed by radiation therapy and chemotherapy to kill any remaining tumor cells and prevent recurrence.

Surgical treatment of glioblastoma requires special skills and experience on the part of the surgeon and must be performed in specialized neurosurgical centers. The decision on the type of surgery and its scope depends on many factors, and doctors always strive to maximize the benefit for the patient with minimal risk.

Radiotherapy

After surgical removal (or sometimes without it), radiation therapy is usually given. This is an important part of glioblastoma treatment, as radiation therapy helps destroy any remaining tumor cells and prevent recurrence.

Radiotherapy is an important part of the treatment of glioblastoma (GBM) and is given after surgical removal of the tumor or debulking (partial removal) to destroy any remaining tumor cells and reduce the risk of recurrence. Here are some key aspects of radiotherapy:

1. Goal of radiotherapy: The main goal of radiotherapy for GBM is to destroy any remaining tumor cells that could not be removed surgically and to reduce the risk of recurrence. Radiotherapy can also shrink the tumor and relieve symptoms.
2. Treatment planning: Before radiation therapy begins, treatment planning is performed, including accurately determining the location of the tumor and calculating the optimal radiation dose. This helps minimize damage to healthy tissue around the tumor.
3. Individualized approach: Radiation therapy treatment is customized for each patient based on many factors, such as tumor location, size, patient's general condition and other medical data.
4. Treatment regimen: A radiation treatment regimen usually involves a series of radiation sessions over a period of time. This may be daily for several weeks. The total radiation dose depends on the specific situation, but is usually between 60 and 70 Gray (Gy).
5. Radiation Therapy Techniques: There are several radiation therapy techniques, including three-dimensional conformational radiotherapy (3D-CRT), intensity modulated radiotherapy (IMRT), strong pulsed radiation (SRS), and others. The doctor chooses the best technique for each individual case.
6. Side effects: Radiotherapy can cause a variety of side effects, such as fatigue, changes in appetite, skin reactions, and more. Doctors can provide support and treatment to manage these effects.
7. Monitoring and follow-up care: After completing radiation therapy, patients usually undergo regular medical monitoring and examinations to monitor their condition and how well the treatment is working. In some cases, additional treatments such as chemotherapy or other therapies may be needed.

Radiotherapy is an important part of multimodal treatment for glioblastoma, and its use is determined on an individual basis. Treatment results may vary depending on the tumor grade, location, and other factors.

Chemotherapy

Chemotherapy is one component of treatment for glioblastoma, a malignant brain tumor. It is used to kill tumor cells and control tumor growth. The main drug often used in chemotherapy for glioblastoma is temozolomide.

Here are some key aspects of chemotherapy for glioblastoma:

1. Preparation and planning: Before chemotherapy begins, your doctor will evaluate your condition, including your medical history, physical examination, and test results. This will help determine how aggressive the tumor is and what chemotherapy regimen is best.
2. Dosage and regimen: Temozolomide is usually taken in tablet form and is taken according to a specific regimen and dosage recommended by your doctor. The regimen may include cycles of taking tablets and periods of rest.
3. Side effects: Chemotherapy can cause side effects such as nausea, vomiting, fatigue, changes in white and red blood cells, and hair loss. The doctor will monitor the patient and provide appropriate treatment and advice to manage these side effects.
4. Evaluating the effectiveness: Your doctor will regularly evaluate the results of chemotherapy using medical tests such as magnetic resonance imaging (MRI) or computed tomography (CT) scans. This will help determine how well the treatment is working and possibly adjust your treatment plan.
5. Combination treatment: Chemotherapy is usually used in combination with other treatments, such as surgical removal of the tumor and radiation therapy, to achieve the best results.

Treatment for glioblastoma is individualized and developed by a doctor based on the specific characteristics of the tumor and the patient's overall condition. It is important to follow the doctor's recommendations and undergo regular medical examinations to monitor the effectiveness of treatment and side effects.

Molecularly targeted therapy

Molecularly targeted therapies for glioblastoma (GBM) are innovative approaches that aim to eliminate specific molecular abnormalities and pathways responsible for tumor growth and survival. However, it should be noted that, unlike some other cancers, molecularly targeted therapies for GBM have not yet achieved the same high levels of efficacy. Here are some key aspects of molecularly targeted therapies for GBM:

1. Molecular characterization of the tumor: For successful molecularly targeted therapy, it is necessary to know the molecular characterization of the tumor, such as the presence of specific genetic mutations or the expression of certain proteins.
2. Individualized approach: Molecularly targeted treatment for GBM often requires an individualized approach for each patient, as molecular abnormalities can vary.
3. Tyrosine kinase inhibitors: Some molecularly targeted therapies include tyrosine kinase inhibitors, which can specifically target specific molecular pathways that promote tumor growth. Examples of these drugs include EGFR (epidermal growth factor) inhibitors or VEGFR (vascular endothelial growth factor receptor) inhibitors.
4. Anti-VEGF therapy: One approach involves anti-VEGF therapy, which aims to inhibit vascular endothelial growth factor (VEGF) and reduce new vessel formation in the tumor, which can starve it of oxygen and nutrients.
5. Immunotherapy: Several clinical trials are investigating the use of immunotherapy to treat GBM, including checkpoint inhibitors and CAR-T cell therapies. These methods attempt to activate the immune system to fight the tumor.
6. Clinical trials: Many of the molecularly targeted therapies for GBM are in clinical trials and their efficacy and safety are being assessed in research programs.
7. Side effects: Like other treatments, molecularly targeted therapy may have side effects that may require medical intervention and monitoring.

It is important to emphasize that molecularly targeted treatments for GBM are still in the research and development phase and are not effective

Symptomatic treatment

Glioblastoma (GBM) is an aggressive and difficult to treat form of glioma, and symptomatic treatment is aimed at relieving symptoms and improving patients' quality of life. Treatment for GBM typically includes the following symptomatic support methods:

1. Pain management: Pain can be one of the most bothersome symptoms of GBM. Pain management involves the use of analgesics, including opioids, and other medications to manage pain.
2. Antiepileptic drugs: Seizures often accompany GBM. Antiepileptic drugs such as levetiracetam (Keppra) or oxcarbazepine (Trileptal) are prescribed to control seizures.
3. Glucocorticoids: Glucocorticoids such as dexamethasone (Decadron) may be used to reduce brain swelling and decrease inflammation, which may help improve symptoms such as headaches and neurological disorders.
4. Antiemetics: Taking antiemetics can help control nausea and vomiting that may occur as a result of GBM treatment or the tumor itself.
5. Rehabilitation: Physical therapy, speech therapy, and other types of rehabilitation may be prescribed to restore or maintain physical and neurological function.
6. Psychological support: A diagnosis of GBM can be emotionally difficult for patients and their families. Psychological support, including counseling and support groups, can help cope with the psychological aspects of the disease.
7. Maintaining Nutrition: Managing your diet and maintaining a healthy weight is important to maintaining strength and vitality.
8. Skin care and ulcer prevention: Patients with GBM may be immobile or have limited mobility, which increases the risk of ulcers and skin problems. Skin care and ulcer prevention are important to maintain healthy skin.

Symptomatic treatment of GBM aims to provide comfort and improve the quality of life of patients in combination with other treatments such as surgery, radiotherapy and chemotherapy. It is important that treatment is individually tailored to each patient’s needs and current condition.

Care and support

Patients with glioblastoma may require intensive medical and psychological support. Family support and psychological counseling also play an important role in treatment.

Treatment of glioblastoma often requires a multidisciplinary approach and individualized planning.

[ 11 ], [ 12 ]

Prevention

There are currently no specific methods for preventing glioblastoma, as the exact causes of this brain tumor are not fully understood. However, there are several general precautions and healthy lifestyle choices that can help reduce the risk of developing a brain tumor and other cancers. Here are some of them:

1. Don't smoke and avoid exposure to toxic substances: Smoking and exposure to toxic substances, such as asbestos or certain chemicals, can increase your risk of cancer. Avoid smoking and exposure to hazardous chemicals.
2. Radiation Protection: Avoid excessive exposure to ionizing radiation, such as X-rays and radiotherapy procedures, unless medically indicated.
3. Healthy Eating: Eat a balanced diet rich in antioxidants and vitamins. Limit processed foods and foods high in sugar and fat.
4. Physical activity: Maintain an active lifestyle and engage in regular physical activity. Physical activity can promote overall health and strengthen the immune system.
5. Stress Management: Try to reduce stress in your daily life. Long-term stress can have negative effects on your health.
6. Check-ups and screenings: Get regular medical check-ups and screenings to detect possible illnesses early and begin treatment if necessary.
7. Genetic counseling: If you have a family history of brain cancer or other tumors, you may want to see a genetic counselor for a risk assessment and monitoring recommendations.

Forecast

The prognosis for glioblastoma depends on several factors, including the stage of the tumor, the patient’s age, overall health, and the availability of effective treatments. GBM is an aggressive and rapidly growing form of glioma, making it difficult to treat and with a poor prognosis. Here are some important aspects of GBM prognosis:

1. Tumor stage: The earlier GBM is detected and treated, the better the prognosis. However, even with early detection, the prognosis remains poor due to the aggressiveness of this tumor.
2. Histologic type: GBM is usually classified as grade IV malignancy according to the WHO (World Health Organization) scale. Higher grades are usually associated with a poorer prognosis.
3. Genetic and molecular characteristics: Certain genetic and molecular abnormalities may influence prognosis and determine sensitivity to various treatments. For example, a mutation in the IDH gene is usually associated with a more favorable prognosis.
4. Treatment: Surgery, radiotherapy and chemotherapy play an important role in the treatment of GBM. The more effective and complete the treatment, the better the prognosis. However, GBM often recurs after initial treatment.
5. General condition of the patient: The general health of the patient and his ability to tolerate treatment also affect the prognosis. Young and physically fit patients usually have a better prognosis.
6. Innovative treatments: Various innovative treatments are currently being investigated, including molecularly targeted treatments and immunotherapy. Research findings may improve prognosis in the future.
7. Recurrence: GBM is prone to recurrence, which worsens the prognosis. Treatment of recurrences is often more difficult and less effective.

Overall, the prognosis for GBM remains poor, and survival depends on many factors. On average, patients with GBM are often diagnosed with a limited lifespan, with median survival being around 12-18 months after diagnosis. However, individual outcomes can vary significantly, and some patients achieve longer survival with modern treatments and participation in clinical trials. Therefore, it is important to seek medical care and specialist advice to determine the best treatment approach.

Life expectancy for glioblastoma

Life expectancy can vary greatly depending on many factors. Glioblastoma usually has aggressive behavior, and the prognosis is often poor. However, modern treatments can improve the prognosis and increase the life expectancy of patients.

Important factors that influence survival time in glioblastoma include:

1. Tumor stage: The earlier glioblastoma is diagnosed, the better the prognosis. Tumors detected at earlier stages are more likely to be successfully removed and are more treatable.
2. Tumor location and size: The location and size of the tumor can affect the ability to surgically remove it and the success of treatment.
3. Patient age: The prognosis is generally poorer for older patients. Younger patients may have a better chance of successful treatment and long-term survival.
4. General health: The patient's general health and the presence of other medical conditions also affect the prognosis.
5. Treatment: Combination treatments, including surgical removal of the tumor, radiation therapy, and chemotherapy, can prolong survival. An individual treatment plan is developed based on the specific characteristics of the tumor and the patient.
6. Molecular markers: Certain molecular markers of a tumor may influence treatment sensitivity and prognosis. For example, the presence of an IDH gene mutation may predict a more favorable outcome.
7. Recurrence: Glioblastoma tends to recur, and recurrent tumors can affect prognosis and life expectancy.

Remember that each case of glioblastoma is unique, and the prognosis depends on many factors. It is important to discuss your prognosis and treatment plan with your doctor, who can provide more accurate information based on the specific circumstances of your case. To make informed decisions, it is important to discuss all aspects of your treatment and health care with your healthcare professionals.

Life expectancy after surgery

Survival after surgery for glioblastoma (GBM) depends heavily on several factors, including tumor stage, patient age, tumor molecular characteristics, availability and effectiveness of additional treatments, and overall health. It is important to understand that GBM is an aggressive and rapidly growing tumor, making treatment and prognosis challenging.

The following factors may affect life expectancy after GBM surgery:

1. Tumor stage: The earlier GBM is detected and removed, the better the prognosis. However, even after surgical removal, GBM often recurs, which complicates the situation.
2. Molecular characteristics: Certain molecular characteristics of the tumor, such as IDH gene mutations, may be associated with a more favorable prognosis.
3. Extent of tumor removal: If the tumor removal was radical and complete, this may increase life expectancy.
4. Treatment after surgery: After surgery, radiation therapy and chemotherapy are often used to kill any remaining tumor cells. The effectiveness of these treatments also affects the prognosis.
5. Patient age: Younger patients usually have a better prognosis.
6. General health: The patient's general health and ability to tolerate treatment can affect the prognosis.
7. Recurrence: GBM is prone to recurrence, and survival after surgery may be significantly reduced if recurrence occurs.

The median survival time for patients with GBM after surgery is about 12-18 months. However, individual results can vary significantly, and some patients achieve longer survival due to modern treatments and participation in clinical trials. The exact prognosis should always be discussed with a physician, and the choice of treatment should be individualized for each patient.

Causes of death from glioblastoma

Death from glioblastoma (GBM) can occur as the tumor progresses and complications associated with it develop. The process of dying from GBM can be physically and emotionally difficult for the patient and their loved ones. Here are some common aspects of how the process of dying from GBM can unfold:

1. Progression of symptoms: As the tumor grows and presses on nearby areas of the brain, symptoms may worsen. This may include increased pain, neurological symptoms (such as paralysis or speech problems), seizures, and cognitive decline.
2. Impaired body functions: GBM can affect various body functions. For example, it can cause breathing problems and respiratory diseases, as the part of the brain that controls these functions can be damaged. The tumor can also affect the function of the heart and other internal organs.
3. Deterioration of general condition: As the disease progresses, patients may lose weight, experience weakness and fatigue, and their appetite may decrease, which may lead to a general weakening of the body.
4. Nursing and palliative care: Patients with GBM often require specialized nursing and palliative care aimed at relieving pain and improving quality of life in the final stages of the disease.
5. Death: The end result of GBM, like many other forms of cancer, is death. This can occur as a result of a variety of complications such as respiratory failure, infections, cardiac failure, and others. Death from GBM can be a slow process, and palliative care can be provided to provide comfort and support to the patient.

It is important to note that each case of GBM is unique, and the course of the disease can vary greatly depending on factors such as the molecular characteristics of the tumor, the effectiveness of treatment, and the overall condition of the patient. Caring for a patient with glioblastoma requires a comprehensive and individualized approach, including support from the medical team, psychological care, and palliative care.